BUPRENORPHINE AND NALOXONE
NDC 67877-606, BUPRENORPHINE AND NALOXONE, tablet, from Ascend Laboratories, LLC.
- Product NDC
- 67877-606
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214930
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/67877-606 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE8 mg/1
- NALOXONE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-606-30 | 67877060630 | 30 TABLET in 1 BOTTLE (67877-606-30) |
| 67877-606-84 | 67877060684 | 3 BLISTER PACK in 1 CARTON (67877-606-84) / 10 TABLET in 1 BLISTER PACK |
| 67877-606-90 | 67877060690 | 90 TABLET in 1 BOTTLE (67877-606-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2e807ed0-6df3-47b5-b7ee-b421c5bf0aa7
Use it
Look up 67877-606 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-606 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-606. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.